Pressana OPC for PAD

About Advanced Catheter Therapies

Advanced Catheter Therapies has developed the Pressana OPC, an FDA-cleared catheter system that creates an isolated treatment chamber in blood vessels for the controlled delivery of liquid therapeutic agents. The device is notably the only actively marketed FDA-cleared liquid drug delivery technology approved for below-the-knee applications, addressing a critical unmet need in preventing amputations from peripheral arterial disease. The company, which has raised $8.87 million and generated $7.8 million in sales and licensing to date, is focused on scaling commercialization through a Series C funding round and expanding its distributor network.

Therapeutic Areas